Question 1

What is Xilio Therapeutics, Inc. (XLO)'s latest shareholders’ equity?

Accepted Answer

Xilio Therapeutics, Inc. (XLO)'s shareholders’ equity for FY2025 was $35.3M, as reported in its SEC filings.

Question 2

How has Xilio Therapeutics, Inc. (XLO)'s shareholders’ equity changed year over year?

Accepted Answer

XLO's shareholders’ equity went from $17.6M in FY2024 to $35.3M in FY2025, an increase of 100.4%.

Question 3

What is the highest shareholders’ equity Xilio Therapeutics, Inc. (XLO) reported over FY2024–FY2025?

Accepted Answer

The highest reported shareholders’ equity over FY2024–FY2025 was $35.3M, in FY2025.

Question 4

What years does this shareholders’ equity history cover?

Accepted Answer

This page shows XLO's shareholders’ equity for each fiscal year from FY2024 to FY2025, drawn from SEC XBRL filings.

Fiscal year	Value	YoY
FY2025	$35.3M	+100.4%
FY2024	$17.6M	—

Xilio Therapeutics, Inc. (XLO) Shareholders’ equity 2024–2025

More XLO financial trends